JEFFREY L. SCHWARTZ


Associate Professor of Radiation Oncology
University of Washington
Box 356069
University of Washington
Seattle, WA 98195

Tel.: (206) 548-4091
Fax: (206) 548-4829

e-mail: jschwart@u.washington.edu
Jeffrey L. Schwartz

 

Education

Research Interests:
  • Radiation Cytogenetics
  • DNA Repair
  • Radiotherapy

Interchromosomal Recombination

Detection of Early Apoptosis with FISH

 

 

 

Ongoing Research Projects:

Molecular Basis of Human Tumor Cell Radioresistance:

The inherent sensitivity of cells within a tumor plays an important role in the response of the tumor to therapy. Our studies have focused on elucidating the molecular basis for differences in the inherent radiation sensitivity of human tumor cells. We have shown that inherent radiation sensitivity differences reflect primarily alterations in chromosome organization and these alterations influence the repair of chromosome breaks. Present studies focus on studying the role of cell cycle checkpoints in response. Understanding the basis for differences in tumor radiosensitivity should aid in the development of biomarkers of response and new approaches to cancer therapy.

Radiation-Induced Chromosome Aberrations in Human Tumor Cell

 

 

 

Mutation Induction by Ionizing Radiation:

There is considerable interest in identifying biomarkers of radiation exposure that not only provide information on dose but also distinguish low LET from high LET exposure. Two potential biomarkers that we have been studying are chromosome aberrations and mutations at the hprt locus. Both endpoints can distinguish radiation-induced alterations from those that occur spontaneously or those induced by most chemical agents. There also appear to be LET-specific alterations in the types of induced chromosome aberrations. Present studies are focused on the influence of cell cycle stage and DNA repair on the frequency and types of mutations induced by radiation. These studies should aid in the development of better models of radiation action, and perhaps suggest approaches for chemoprevention.

 

DNA Sequence of Mutated HPRT Gene

Radiation-Induced Genome Instability and Therapy Response:

Genomic instability is defined as the increased rate of acquisition of alterations in the mammalian genome. The induction of genome instability is considered an important prerequisite to cancer formation. Genome instability has also been suggested to contribute to the development of resistance to cancer therapy. Instability can develop spontaneously or it can also be induced by exposure to agents such as ionizing radiation. The goal of our studies is to identify markers of instability and use these markers to examine the hypothesis that instability is induced in tumors during a standard fractionated radiation treatment, and that this induced genome instability contributes to radiotherapy resistance.

Telomere Size in Stable and Unstable Clones of WTK1 Cells.

Recent Publications:

Schwartz J L. Alterations in chromosome structure and variations in the inherent radiation sensitivity of human cells. Radiation Research. 149(4): 319-24, Apr 1998.

Schwartz J L;Hsie A W. Genetic and cytogenetic markers of exposure to high-linear energy transfer radiation. Radiation Research. 148(5 Suppl): S87-92, Nov 1997.

Rotmensch J;Whitlock J L;Schwartz J L;Hines J J;Reba R C;Harper P V. In vitro and in vivo studies on the development of the alpha-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma. American Journal of Obstetrics and Gynecology. 176(4): 833-40; discussion 8, Apr 1997.

Schwartz J L;Jordan R. Selective elimination of human lymphoid cells with unstable chromosome aberrations by p53-dependent apoptosis. Carcinogenesis. 18(1): 201-5, Jan 1997.

Schwartz J L;Mustafi R;Hughes A;DeSombre E R. DNA and chromosome breaks induced by iodine-123-labeled estrogen in Chinese hamster ovary cells. Radiation Research. 146(2): 151-8, Aug 1996.

Schwartz J L;Cowan J;Grdina D J;Weichselbaum R R. Attenuation of G2-phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiation Research. 146(2): 139-43, Aug 1996.

Schwartz J L;Mustafi R;Beckett M A;Weichselbaum R R. DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy. British Journal of Cancer. 74(1): 37-42, Jul 1996.

Hsie A W;Porter R C;Xu Z;Yu Y;Sun J;Meltz M L;Schwartz J L. Molecular markers of ionizing radiation-induced gene mutations in mammalian cells. Environmental Health Perspectives. 104 Suppl 3: 675-8, May 1996.

Schwartz J L;Porter R C;Hsie A W. The molecular nature of spontaneous mutations at the hprt locus in the radiosensitive CHO mutant xrs-5. Mutation Research. 351(1): 53-60, 26 Mar 1996.

DeSombre E R;Hughes A;Landel C C;Greene G;Hanson R;Schwartz J L. Cellular and subcellular studies of the radiation effects of Auger electron-emitting estrogens. Acta Oncologica. 35(7): 833-40, 1996.

Research Society Links

 

 

Hear a chromosome break!

 

To: Radiation Oncology Departmental Homepage